Genetic Polymorphisms of Interleukin-10 and TNF-α on Outcome of HCV-Related Chronic Liver Disease

Sponsor
Kaohsiung Medical University Chung-Ho Memorial Hospital (Other)
Overall Status
Unknown status
CT.gov ID
NCT00630006
Collaborator
(none)
3
23

Study Details

Study Description

Brief Summary

The prognosis of chronic hepatitis C virus (HCV)infeciton varies from minimal progressive disease to cirrhosis or hepatocellular carcinoma. Host genetic factors contribute to disease severity. It is known that cytokine gene (including tumor necrosis factor-alpha (TNF-alpha) and interleukin-10 (IL-10) polymorphism affect disease prognosis.This study aims to assess the effect of TNF-alpha and IL-10, and their interaction,on prognosis of HCV-related chronic liver disease

Condition or Disease Intervention/Treatment Phase
  • Genetic: TNF-alpha and IL-10
N/A

Study Design

Study Type:
Interventional
Allocation:
Randomized
Intervention Model:
Factorial Assignment
Masking:
None (Open Label)
Study Start Date :
Jan 1, 2007
Anticipated Study Completion Date :
Dec 1, 2008

Outcome Measures

Primary Outcome Measures

  1. cytokine gene polymorphism [years]

Secondary Outcome Measures

  1. cytokine gene polymorphism on severity of disease [years]

Eligibility Criteria

Criteria

Ages Eligible for Study:
N/A and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • Anti-HCV-positive patients
Exclusion Criteria:
  • Anti-HCV-negative patients

Contacts and Locations

Locations

Site City State Country Postal Code
1 Kaohsiung Medical University Chung-Ho Memorial Hospital Kaohsiung Taiwan 807
2 Kaohsiung Medical University Chung-Ho Memorial Hospital Kaohsiung Taiwan 807
3 Kaohsiung Medical University Chung-Ho Memorial Hospital Kaohsiung Taiwan 807

Sponsors and Collaborators

  • Kaohsiung Medical University Chung-Ho Memorial Hospital

Investigators

  • Principal Investigator: Jen-Eing Jeng, M.D., Assistant Professor

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
, ,
ClinicalTrials.gov Identifier:
NCT00630006
Other Study ID Numbers:
  • KMUH-IRB-950182
First Posted:
Mar 6, 2008
Last Update Posted:
Mar 6, 2008
Last Verified:
Jul 1, 2007
Additional relevant MeSH terms:

Study Results

No Results Posted as of Mar 6, 2008